In this video we discuss promising results of the anti–PD-L1 agent avelumab in patients with metastatic Merkel cell carcinoma who had previously been treated with chemotherapy.
Howard L. Kaufman, MD
Advertisement
Articles by Howard L. Kaufman, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
I-DXd Earns FDA Priority Review in Extensive-Stage Small Cell Lung Cancer
2
FDA Grants Fast Track Designation to Daretabart for High-Risk Neuroblastoma
3
Daraxonrasib Shows "Unprecedented" Survival in Pretreated Pancreatic Cancer
4
REGN5668 Combo Yields Preliminary Activity in Recurrent Ovarian/Endometrial Cancer
5